Ash Nagpal
Director, LNP Process Development Nava Therapeutics
Seminars
Tuesday 7th April 2026
Developing Scalable & Modular Targeted LNPs for Accelerating LNP-Based Programs from Research to Clinical Approval
2:30 pm
- Mitigating targeted LNP scalability risks by delving into translational hurdles and ensuring manufacturing readiness from early research stages
- Leveraging platform modularity to rapidly advance of targeted LNP programs across diverse therapeutic targets
